The development objective of the Support to Coronavirus Disease 2019 (COVID-19) Vaccine Purchase and Health System Strengthening Project for Madagascar is to prevent, detect, and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. The project comprises of three components. The first component, acquisition of project COVID-19 vaccines and medical supplies will finance vaccination supplies needed for vaccine delivery and distribution. The second component, strengthening health system for the effective deployment of project COVID-19 vaccines will support the deployment of vaccines and key investments in the health system which are essential to ensure effective delivery of COVID-19 vaccines and strengthening the health system in the long-term. It consists of following sub-components: (i) strengthening logistics, cold chain, and vaccination sites; (ii) strengthening surveillance and information systems; (iii) strengthening capacity for managing and implementing immunization campaigns; (iv) strengthening communication and addressing vaccine hesitancy; and (v) project implementation and monitoring. The third component, contingent emergency response will facilitate access to rapid financing by allowing for the reallocation of uncommitted project funds in the event of a natural disaster, either by a formal declaration of a national emergency or upon a formal request from the government.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | World Bank – IBRD |
|---|
| Country | Republic of Madagascar |
|---|
| Category | Pharmaceuticals |
|---|
| Published | June 24, 2021 |
|---|
| Procurement stage | Active solicitation |
|---|
| Closed | June 24, 2021 |
|---|
| Status | Closed — no longer accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | August 12, 2026 |
|---|
Source: The World Bank — Open Data, licensed CC BY 4.0.
See every Republic of Madagascar Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free Republic of Madagascar Pharmaceuticals intelligence report in your inbox
A personalized report on Republic of Madagascar Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.